These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9878198)
41. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease. Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168 [TBL] [Abstract][Full Text] [Related]
44. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. Alfinito PD; Wang SP; Manzino L; Rijhsinghani S; Zeevalk GD; Sonsalla PK J Neurosci; 2003 Nov; 23(34):10982-7. PubMed ID: 14645494 [TBL] [Abstract][Full Text] [Related]
45. Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons. Fatokun AA; Smith RA; Stone TW Brain Res; 2008 Jun; 1215():200-7. PubMed ID: 18486115 [TBL] [Abstract][Full Text] [Related]
46. Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation. Ferger B; Eberhardt O; Teismann P; de Groote C; Schulz JB J Neurochem; 1999 Sep; 73(3):1329-32. PubMed ID: 10461928 [TBL] [Abstract][Full Text] [Related]
47. Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. Frim DM; Simpson J; Uhler TA; Short MP; Bossi SR; Breakefield XO; Isacson O J Neurosci Res; 1993 Jul; 35(4):452-8. PubMed ID: 8103116 [TBL] [Abstract][Full Text] [Related]
48. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females. Murray HE; Pillai AV; McArthur SR; Razvi N; Datla KP; Dexter DT; Gillies GE Neuroscience; 2003; 116(1):213-22. PubMed ID: 12535954 [TBL] [Abstract][Full Text] [Related]
49. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Filloux F; Townsend JJ Exp Neurol; 1993 Jan; 119(1):79-88. PubMed ID: 8432353 [TBL] [Abstract][Full Text] [Related]
50. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Beal MF; Henshaw DR; Jenkins BG; Rosen BR; Schulz JB Ann Neurol; 1994 Dec; 36(6):882-8. PubMed ID: 7998775 [TBL] [Abstract][Full Text] [Related]
51. Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats. Guyot MC; Palfi S; Stutzmann JM; Mazière M; Hantraye P; Brouillet E Neuroscience; 1997 Nov; 81(1):141-9. PubMed ID: 9300407 [TBL] [Abstract][Full Text] [Related]
52. In vivo vulnerability of dopamine neurons to inhibition of energy metabolism. Zeevalk GD; Manzino L; Hoppe J; Sonsalla P Eur J Pharmacol; 1997 Feb; 320(2-3):111-9. PubMed ID: 9059843 [TBL] [Abstract][Full Text] [Related]
53. Role of corticostriatal and nigrostriatal inputs in malonate-induced striatal toxicity. Meldrum A; Dunnett SB; Everitt BJ Neuroreport; 2001 Jan; 12(1):89-93. PubMed ID: 11201098 [TBL] [Abstract][Full Text] [Related]
54. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. Brouillet E; Guyot MC; Mittoux V; Altairac S; Condé F; Palfi S; Hantraye P J Neurochem; 1998 Feb; 70(2):794-805. PubMed ID: 9453576 [TBL] [Abstract][Full Text] [Related]
56. Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease. Kodsi MH; Swerdlow NR Neurosci Lett; 1997 Aug; 231(2):103-7. PubMed ID: 9291151 [TBL] [Abstract][Full Text] [Related]
57. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies. Ouary S; Bizat N; Altairac S; Ménétrat H; Mittoux V; Condé F; Hantraye P; Brouillet E Neuroscience; 2000; 97(3):521-30. PubMed ID: 10828534 [TBL] [Abstract][Full Text] [Related]
60. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. McLaughlin BA; Nelson D; Erecińska M; Chesselet MF J Neurochem; 1998 Jun; 70(6):2406-15. PubMed ID: 9603205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]